Connection

Paolo Gisondi to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Back to Details
This is a "connection" page, showing publications Paolo Gisondi has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
Paolo Gisondi
Connection Strength
0.705
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  1. Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin. J Dermatol. 2017 Dec; 44(12):e332-e333.
    View in: PubMed
    Score: 0.705
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.